Welcome to our dedicated page for Chimera Invt SEC filings (Ticker: CIM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Chimera Investment Corporation (NYSE: CIM) SEC filings page on Stock Titan brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, including Forms 8-K, 10-K, 10-Q, registration statements, and related exhibits. Chimera is a mortgage-focused real estate investment trust that invests in residential mortgage loans, Non-Agency RMBS, Agency RMBS, Agency CMBS, mortgage servicing rights (MSRs), business purpose and investor loans, and other real estate-related assets, and its filings provide detailed insight into these activities.
Recent Form 8-K filings cover a range of material events: quarterly earnings releases, common and preferred stock dividend declarations, public offerings of senior notes, and the completion of the acquisition of HomeXpress Mortgage Corp. These current reports often include or reference press releases, investor presentations, underwriting agreements, indentures, inducement award plans, and pro forma financial information.
Chimera’s periodic reports, such as its Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, which are referenced in its 8-K risk factor supplements, discuss its mortgage asset portfolio, leverage, consolidated variable interest entities (VIEs), investment management and advisory services, and extensive risk factors related to funding, credit, interest rates, regulation, and REIT status. These filings also address the company’s use of non-GAAP measures like earnings available for distribution.
On this page, Stock Titan enhances Chimera’s filings with AI-powered summaries that explain key sections of lengthy documents, highlight important changes, and surface items such as new debt issuances, acquisition terms, and updates to risk factors. Users can quickly scan new 8-Ks for dividend actions or capital markets transactions, and review 10-Q and 10-K discussions of mortgage assets, securitizations, and leverage.
In addition, this page tracks registered securities and senior notes listed in Chimera’s filings, including its common stock, multiple series of cumulative redeemable preferred stock, and senior notes due 2029 and 2030. Investors can use the filings archive and AI summaries to monitor Chimera’s capital structure, financing activities, and ongoing compliance disclosures in one place.
Chimera Investment Corporation launched and priced a registered underwritten public offering of $115 million aggregate principal amount of 8.875% Senior Notes due 2030. The company also granted the underwriters a 30-day option to buy up to an additional $17.25 million of these notes to cover any over-allotments.
The notes are being issued under an effective shelf registration statement on Form S-3 and a related prospectus supplement dated September 9, 2025. Chimera entered into an underwriting agreement with a syndicate led by Morgan Stanley, RBC Capital Markets, UBS, Wells Fargo Securities, Keefe, Bruyette & Woods, and Piper Sandler, which includes customary representations, covenants and indemnification provisions. The offering is scheduled to close on September 16, 2025, subject to customary closing conditions.
Chimera Investment Corp. (CIM) is offering debt securities with an aggregate principal amount of $115.0 million (per note price $25.00), with an over-allotment option increasing aggregate proceeds to $132.25 million. The company intends to use net proceeds to acquire mortgage-related assets including residential mortgage loans, Non-Agency RMBS, Agency RMBS, Agency CMBS and mortgage servicing rights, and for general corporate purposes.
As of June 30, 2025, consolidated indebtedness totaled $11.7 billion (about $11.6 billion secured; $140.0 million unsecured). The investment portfolio mix at June 30, 2025 was ~74% residential mortgage loans, 19% Agency MBS, 7% Non-Agency RMBS, down from 88% residential loans at year-end 2024. The prospectus notes an acquisition of HomeXpress Mortgage Corp. through a Stock Purchase Agreement assigned to Chimera Funding TRS LLC, making HomeXpress an indirect wholly-owned subsidiary upon closing. The indenture places no financial covenants and permits issuer optional redemption on or after August 15, 2027 at par plus accrued interest.
Chimera Investment Corp. is offering debt securities to fund acquisitions of mortgage-related assets and for general corporate purposes. As of June 30, 2025, the company reported $11.7 billion of consolidated indebtedness, of which approximately $11.6 billion was secured and about $140.0 million was unsecured (represented by senior notes). The company intends to use net proceeds to acquire residential mortgage loans, Non-Agency RMBS, Agency RMBS, Agency CMBS, mortgage servicing rights and related assets and to repay or pay down liabilities. Portfolio composition shifted between Dec 31, 2024 and June 30, 2025: residential mortgage loans represented ~74% of the investment portfolio at June 30, 2025 (vs ~88% at Dec 31, 2024), Agency MBS ~19% (vs 4%), and Non-Agency RMBS ~7% (vs 8%). The prospectus notes an acquisition of HomeXpress Mortgage Corp. via a subsidiary and specifies that the indenture for the notes will not include financial covenants or limits on additional indebtedness. The offering contemplates maintaining proceeds in short-term investment-grade securities pending deployment and describes withholding and tax treatment for non-U.S. noteholders and stockholders.